• Sun. Jan 23rd, 2022

DMC News

We Report As It Is

SAHPRA approves Pfizer booster shots for adults, immunocompromised children


Dec 8, 2021

The South African Health Products Authority (SAHPRA) announced the approval of a third dose – or booster shot – of the Pfizer COVID-19 vaccine for individuals aged 18 and older, on Wednesday, 8 December.

Children aged 12 and older with compromised immune systems are also eligible for another dose.


SAHPRA said it received an application from Pfizer to amend the dosing schedule for the Pfizer (Comirnaty) COVID-19 vaccine to allow for an optional third dose on 17 November 2021.

The authority said that after evaluating the data submitted it has approved the booster dose as follows:

A third dose of the Comirnaty COVID-19 vaccine in individuals aged 18 and older, to be administered at least six months after the second dose.A third dose of the Comirnaty COVID-19 vaccine in individuals aged 12 years and older who are severely immunocompromised, to be administered at least 28 days after the second dose.

SAHPRA said the data it dealt with only looked at scenarios where the third dose is of the same vaccine as the initial course. Therefore, members of the public who received a Johnson and Johnson vaccine will not be able to receive another jab yet.

“SAHPRA is aware of the keen interest in the efficacy and safety of heterologous boosting regimens (so-called ‘mix and match’ approaches) and invites submission of supportive data in this regard,” said the Authority’s CEO Dr Boitumelo Semete


Leave a Reply

Your email address will not be published. Required fields are marked *